A detailed history of Caption Management, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 13,778 shares of STIM stock, worth $27,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,778
Holding current value
$27,142
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$2.63 - $4.66 $36,236 - $64,205
13,778 New
13,778 $36,000
Q1 2022

May 13, 2022

SELL
$2.84 - $4.52 $101,947 - $162,254
-35,897 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$6.22 - $15.54 $223,279 - $557,839
35,897 New
35,897 $235,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $53.2M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.